Clinical trial

Exploratory Efficacy Study of NEUROSTEM® in Subjects Who Control Group of NEUROSTEM®

NCT04954534

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2021-07-12

PhaseNA

Study timeline

Study start (estimated)2021-07-12Date precision: day

Registry last updated2021-07-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Alzheimer's Diseaseunresolved

Interventions

human umbilical cord blood derived mesenchymal stem cellsBIOLOGICAL

Sponsors & collaborators

Samsung Medical Centerlead sponsor

Medipost Co Ltd.collaborator

Mapped research locations

SeoulSouth Korea1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04954534 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.